Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Brandon Swift

6PUBLICATIONS
8CO-AUTHORS
Characterisation of biological macromoleculesMedical biochemistry - lipidsBasic pharmacologyAllergyToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Feb 13, 2025
Analysis of C4 Concentrations to Predict Impact of Patient-Reported Diarrhea Associated With the Ileal Bile Acid Transporter Inhibitor Linerixibat.

Fernando Carreño, Rashmi Mehta, Andrea Ribeiro de Souza

|May 23, 2024
Serum bile acid change correlates with improvement in pruritus in patients with primary biliary cholangitis receiving linerixibat.

Eleni Karatza, Brandon Swift, Fernando Carreño

|Dec 23, 2023
Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract-Case Study: Tenapanor.

Konstantinos Stamatopoulos, Nena Mistry, Nikoletta Fotaki

|Nov 13, 2023
Population Dose-Response-Time Analysis of Itch Reduction and Patient-Reported Tolerability Supports Phase III Dose Selection for Linerixibat.

Fernando Carreño, Eleni Karatza, Rashmi Mehta

|Jan 16, 2023
Clinical assessment of gepotidacin (GSK2140944) as a victim and perpetrator of drug-drug interactions via CYP3A metabolism and transporters.

Aline Barth, Caroline R Perry, Shaila Shabbir

|Jun 30, 2022
Pharmacokinetics, safety, and tolerability of gepotidacin administered as single or repeat ascending doses, in healthy adults and elderly subjects.

Courtney Tiffany, Etienne F Dumont, Mohammad Hossain

Pageof 1

Frequent Collaborators

2 joint publications

Meenakshi Srinivasan

1 joint publications

Konstantinos Stamatopoulos

1 joint publications

Nikoletta Fotaki

1 joint publications

Janelle Lennie

1 joint publications

Andreas E Kremer

1 joint publications

Fernando Carreño

1 joint publications

Rashmi Mehta

1 joint publications

Jon Collins

Frequent Collaborators

2 joint publications

Meenakshi Srinivasan

1 joint publications

Konstantinos Stamatopoulos

1 joint publications

Nikoletta Fotaki

1 joint publications

Janelle Lennie

Top Related Videos

A Protocol to Characterize the Morphological Changes of <em>Clostridium difficile</em> in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of <em>Clostridium difficile</em> in Response to Antibiotic Treatment

Published on : May 25, 2017

8.9K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on : Feb 10, 2015

52.2K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on : Dec 03, 2020

7.9K
See more related videos

Top Related Videos

A Protocol to Characterize the Morphological Changes of <em>Clostridium difficile</em> in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of <em>Clostridium difficile</em> in Response to Antibiotic Treatment

Published on : May 25, 2017

8.9K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on : Feb 10, 2015

52.2K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on : Dec 03, 2020

7.9K
See more related videos